Rituximab Therapy in Pulmonary Alveolar Proteinosis: A Rare Case Report
Pulmonary Alveolar Proteinosis (PAP) is a rare disorder characterised by accumulation of surfactant in alveoli due to impaired surfactant clearance. Although, whole lung lavage is the standard treatment of PAP, rituximab has also been introduced as a therapeutic option for PAP. A 49-year-old female...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2018-04-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/11419/32371_CE[Ra1]_CE[EK]_F(SL)_PF1(EK_SL)_PFA(EK_SL)_PB(EK_SL)_PN(SL).pdf |